Visual acuity and foveal thickness after fitrectomy for macular edema

Ophthalmologica

Volumn 224, Issue 6, 2010, Pages 367-373

  Noma, Hidetaka ^a,b   Funatsu, Hideharu ^a   Mimura, Tatsuya ^c   Shimada, Katsunori ^d  

^a Tokyo Women s Medical University   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d STATZ Institute Inc   (Japan)

Author keywords

Central retinal vein occlusion; Foveal thickness; Macular edema; Vitrectomy

Indexed keywords

INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; FEMALE; HUMAN; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; RETINA; RETINA FOVEA; RETINA MACULA EDEMA; THICKNESS; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYEGLASSES; FEMALE; FOVEA CENTRALIS; HUMANS; INTERLEUKIN-6; MACULAR EDEMA; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 77951969527     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313819     Document Type: Article

References (32)

1. Hayreh SS: Classification of central retinal vein occlusion. Ophthalmology 1983; 90: 458-474.
2. Gutman FA, Zegarra H: Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984; 28(suppl):462-470.
3. Zegarra H, Gutman FA, Conforto J: The natural course of central retinal vein occlusion. Ophthalmology 1979; 86: 1931-1942.
4. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487.
5. Chen KH, Wu CC, Roy S, Lee SM, Liu JH: Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 1999; 40: 2627-2632.
6. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E: Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998; 105: 412-416.
7. Noma H, Funatsu H, Mimura T, Harino S, Hori S: Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to macular edema with central retinal vein occlusion. Ophthalmology 2009; 116: 87-93.
8. Noma H, Funatsu H, Mimura T, Harino S, Sone T, Hori S: Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Acta Ophthalmol, in press.
9. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-985.
10. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271: 736-741.
11. Maruo N, Morita I, Shirao M, Murota S: IL-6 increases endothelial permeability in vitro. Endocrinology 1992; 131: 710-714.
12. Behzadian MA, Wang XL, Shabrawey M, Caldwell RB: Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia 1998; 24: 216-225.
13. Leizaola-Fernández C, Suárez-Tatá L, Quiroz- Mercado H, Colina-Luquez J, Fromow- Guerra J, Jiménez-Sierra JM, Guerrero- Naranjo JL, Morales-Cantón V: Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol 2005; 5: 10.
14. Tachi N, Hashimoto Y, Ogino N: Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999; 97: 465-469.
15. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK: Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140: 256-261.
16. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995; 102: 1425-1433.
17. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993; 111: 1087-1095.
18. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997; 115: 486-491.
19. Otani T, Kishi S: Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 2000; 129: 487-494.
20. Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H, Mishima HK: Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006; 244: 309-315.
21. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK: Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008; 22: 42-48.
22. Hogan MJ, Alvarado JA, Weddell JE: Histology of the Human Eye: An Atlas and Textbook. Philadelphia, Saunders 1971, p 492.
23. Fine BS, Brucker AJ: Macular edema and cystoid macular edema. Am J Ophthalmol 1981; 92: 466-481.
24. Tso MO: Pathology of cystoid macular edema. Ophthalmology 1982; 89: 902-915.
25. Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr: Pathology of human cystoid macular edema. Surv Ophthalmol 1984; 28(suppl):505-511.
26. Yamasaki M, Noma H, Funatsu H, Minamoto A, Mimura T, Shimada K, Yamashita H, Kiuchi Y: Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Int Ophthalmol 2009; 29: 161-167.
27. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103: 1820-1828.
28. Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, Sorenson J, Slakter JS, Freund KB, Cooney M, Fine HF: Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006; 26: 279-284.
29. Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK, Babu RB, Narayana KM: Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007; 143: 601-606.
30. Noma H, Funatsu H, Mimura T, Hori S: Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol 2008; 18: 1017-1019.
31. Suzuma K, Kita M, Yamana T, Ozaki S, Takagi H, Kiryu J, Ogura Y: Quantitative assessment of macular edema with retinal vein occlusion. Am J Ophthalmol 1998; 126: 409-416.
32. Imasawa M, Iijima H, Morimoto T: Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion. Am J Ophthalmol 2001; 131: 55-60.